Works matching IS 10837159 AND DT 2018 AND VI 23
Results: 259
Conflicts of Interest, Baselga, and Clinical Trialists.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1394, doi. 10.1634/theoncologist.2018-0663
- By:
- Publication type:
- Article
Conflict of Interest: An Ethical Firestorm with Consequences for Cancer Research.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1391, doi. 10.1634/theoncologist.2018-0662
- By:
- Publication type:
- Article
Modulation of Premetastatic Niche by the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Localized High‐Risk Prostate Cancer Followed by Radical Prostatectomy: A Phase II Randomized Trial.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1413, doi. 10.1634/theoncologist.2018-0652
- By:
- Publication type:
- Article
Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1533, doi. 10.1634/theoncologist.2018-0095
- By:
- Publication type:
- Article
FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim‐Chester Disease with the BRAFV600 Mutation.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1520, doi. 10.1634/theoncologist.2018-0295
- By:
- Publication type:
- Article
Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1401, doi. 10.1634/theoncologist.2018-0163
- By:
- Publication type:
- Article
Premature Clinical Trial Discontinuation in the Era of Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1494, doi. 10.1634/theoncologist.2018-0003
- By:
- Publication type:
- Article
Alerta Rosa: Novel Alert and Navigation Breast Cancer Program in Nuevo Leon, Mexico, for Reducing Health System Interval Delays.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1461, doi. 10.1634/theoncologist.2018-0226
- By:
- Publication type:
- Article
Randomized, Open‐Label Phase II Study Comparing Capecitabine‐Cisplatin Every 3 Weeks with S‐1‐Cisplatin Every 5 Weeks in Chemotherapy‐Naïve Patients with HER2‐Negative Advanced Gastric Cancer: OGSG1105, HERBIS‐4A Trial
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1411, doi. 10.1634/theoncologist.2018-0175
- By:
- Publication type:
- Article
Intracranial Response to Anti‐Programmed Death 1 Therapy in a Patient with Metastatic Non‐Small Cell Lung Cancer with Leptomeningeal Carcinomatosis.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. e159, doi. 10.1634/theoncologist.2018-0022
- By:
- Publication type:
- Article
A Phase I Dose‐Escalation Study of Linsitinib (OSI‐906), a Small‐Molecule Dual Insulin‐Like Growth Factor‐1 Receptor/Insulin Receptor Kinase Inhibitor, in Combination with Irinotecan in Patients with Advanced Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1409, doi. 10.1634/theoncologist.2018-0315
- By:
- Publication type:
- Article
Pertuzumab: Getting the Balance Right.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic Mastocytosis.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1511, doi. 10.1634/theoncologist.2018-0222
- By:
- Publication type:
- Article
Multilevel Factors Affecting Time to Cancer Diagnosis and Care Quality in Botswana.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1453, doi. 10.1634/theoncologist.2017-0643
- By:
- Publication type:
- Article
In Reply.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open‐Label, Phase I Trial (JVDF).
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1407, doi. 10.1634/theoncologist.2018-0044
- By:
- Publication type:
- Article
Tumor Molecular Testing Guides Anti‐PD‐1 Therapy and Provides Evidence for Pathogenicity of Mismatch Repair Variants.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1395, doi. 10.1634/theoncologist.2018-0108
- By:
- Publication type:
- Article
In Reply.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Tumor Lysis Syndrome in the 21st Century: To Recreate Risk Factors and Prognosis?
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Reflections on the Boston Marathon from a Breast Cancer Oncologist (or, Why I Just Don't Quit).
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1548, doi. 10.1634/theoncologist.2018-0262
- By:
- Publication type:
- Article
Fear of Mastectomy Associated with Delayed Breast Cancer Presentation Among Ghanaian Women.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1446, doi. 10.1634/theoncologist.2017-0409
- By:
- Publication type:
- Article
Prognostic Nomogram Based on Histological Characteristics of Fibrotic Tumor Stroma in Patients Who Underwent Curative Resection for Intrahepatic Cholangiocarcinoma.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1482, doi. 10.1634/theoncologist.2017-0439
- By:
- Publication type:
- Article
Volume 23 Author Index.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. e167, doi. 10.1634/theoncologist.2018-a000
- Publication type:
- Article
In the Patient's Shoes.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1546, doi. 10.1634/theoncologist.2017-0525
- By:
- Publication type:
- Article
Cluster Analysis Demonstrates the Need to Individualize Care for Cancer Survivors.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1474, doi. 10.1634/theoncologist.2017-0558
- By:
- Publication type:
- Article
Association Between Serum Folate Level and Toxicity of Capecitabine During Treatment for Colorectal Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1436, doi. 10.1634/theoncologist.2017-0637
- By:
- Publication type:
- Article
Meta‐Research on Oncology Trials: A Toolkit for Researchers with Limited Resources.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1467, doi. 10.1634/theoncologist.2018-0043
- By:
- Publication type:
- Article
Volume 23 Acknowledgments.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. e179, doi. 10.1634/theoncologist.2018-r000
- Publication type:
- Article
Machine Learning for Better Prognostic Stratification and Driver Gene Identification Using Somatic Copy Number Variations in Anaplastic Oligodendroglioma.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1500, doi. 10.1634/theoncologist.2017-0495
- By:
- Publication type:
- Article
2018 Chabner Colloquium: Answering the Big Questions in Cancer Research Annual Meeting Abstracts.
- Published in:
- 2018
- Publication type:
- Abstract
Non‐Small Cell Lung Cancer in Countries of Central and Southeastern Europe: Diagnostic Procedures and Treatment Reimbursement Surveyed by the Central European Cooperative Oncology Group.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. e152, doi. 10.1634/theoncologist.2018-0008
- By:
- Publication type:
- Article
Predictors of Location of Death for Children with Cancer Enrolled on a Palliative Care Service.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1525, doi. 10.1634/theoncologist.2017-0650
- By:
- Publication type:
- Article
Antitumor Effect of Nivolumab on Subsequent Chemotherapy for Platinum‐Resistant Ovarian Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1382, doi. 10.1634/theoncologist.2018-0167
- By:
- Publication type:
- Article
Esophageal Metal Stents with Concurrent Chemoradiation Therapy for Locally Advanced Esophageal Cancer: Safe or Not?
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1426, doi. 10.1634/theoncologist.2017-0646
- By:
- Publication type:
- Article
Quantitative Proteomics Analysis of Sporadic Medullary Thyroid Cancer Reveals FN1 as a Potential Novel Candidate Prognostic Biomarker.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1415, doi. 10.1634/theoncologist.2017-0399
- By:
- Publication type:
- Article
Comparative Effectiveness of an mTOR‐Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple‐Negative Breast Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1300, doi. 10.1634/theoncologist.2017-0498
- By:
- Publication type:
- Article
Clinicopathological and Treatment‐Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1289, doi. 10.1634/theoncologist.2018-0200
- By:
- Publication type:
- Article
Interferon‐α Is Effective for Treatment of Minimal Residual Disease in Patients with t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Registry Study.
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1349, doi. 10.1634/theoncologist.2017-0692
- By:
- Publication type:
- Article
Prognostic Factors in Patients with Metastatic Breast Cancer with Bone‐Only Metastases.
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1282, doi. 10.1634/theoncologist.2018-0085
- By:
- Publication type:
- Article
Amyloid Precursor Protein Is Associated with Aggressive Behavior in Nonluminal Breast Cancers.
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1273, doi. 10.1634/theoncologist.2018-0012
- By:
- Publication type:
- Article
Single‐Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial).
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1271, doi. 10.1634/theoncologist.2018-0316
- By:
- Publication type:
- Article
Barriers to Oncology Biosimilars Uptake in the United States.
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1261, doi. 10.1634/theoncologist.2018-0066
- By:
- Publication type:
- Article
Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer‐Associated Thrombosis: The Observational ROADMAP‐CAT Study.
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1372, doi. 10.1634/theoncologist.2017-0530
- By:
- Publication type:
- Article
A Phase I Study of Ganetespib and Ziv‐Aflibercept in Patients with Advanced Carcinomas and Sarcomas.
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1269, doi. 10.1634/theoncologist.2018-0203
- By:
- Publication type:
- Article
Disparities in the Use of Programmed Death 1 Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1388, doi. 10.1634/theoncologist.2017-0673
- By:
- Publication type:
- Article
FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B‐Cell Acute Lymphoblastic Leukemia.
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1366, doi. 10.1634/theoncologist.2018-0179
- By:
- Publication type:
- Article
The Importance of Distinguishing Sporadic Cancers from Those Related to Cancer Predisposing Germline Mutations.
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1266, doi. 10.1634/theoncologist.2017-0681
- By:
- Publication type:
- Article
Seminoma with Neoplastic Meningitis Treated with Craniospinal Irradiation.
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1385, doi. 10.1634/theoncologist.2017-0223
- By:
- Publication type:
- Article
Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1319, doi. 10.1634/theoncologist.2018-0143
- By:
- Publication type:
- Article
Association of Immune‐Related Adverse Events with Clinical Benefit in Patients with Advanced Non‐Small‐Cell Lung Cancer Treated with Nivolumab.
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1358, doi. 10.1634/theoncologist.2017-0384
- By:
- Publication type:
- Article